CIPLA recalls
Every recall we track for CIPLA — 11 in all, from 2020–2022 — plus the complaints and injury reports the public filed about them. 4 are rated “stop using now”.
Recalls per year, by danger level
Recalls from CIPLA peaked in 2022 (6); 11 since 2017. 36% rated “stop using now”.
All FDA recall records for CIPLA since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 1 | 2 | 0 | 4 |
| 2021 | 0 | 0 | 0 | 1 | 1 |
| 2022 | 3 | 2 | 1 | 0 | 6 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled CIPLA product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All CIPLA recalls
8 shown- Stop using nowDrug
CIPLA recalls Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile
Cipla recalls certain batches of Arformoterol Tartrate Inhalation Solution due to environmental monitoring failure causing lack of sterility. This could lead to infections if used.
CiplaSep 29, 2022 - Stop using nowDrug
CIPLA recalls Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules
Cipla recalls 0.25mg/2mL Budesonide inhalation suspension due to lack of sterility assurance. Affected lots expire 01/2024. Stop using immediately if you have this prescription medication.
CiplaSep 15, 2022 - Stop using nowDrug
CIPLA recalls Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecuticals, Inc., Boca
CIPLA recalls 0.05% Difluprednate Ophthalmic Emulsion bottles due to potential contamination from broken protective caps. This medication is prescription-only and may cause eye infections if not sterile.
CIPLAAug 22, 2022 - Lower riskDrug
CIPLA recalls Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd.,
CIPLA recalls 5mL Difluprednate Ophthalmic Emulsion 0.05% bottles due to container closure defects that may compromise sterility. Affected lots manufactured in India for Cipla USA.
CIPLAAug 2, 2022 - Use cautionDrug
CIPLA recalls Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies
Cipla recalls 0.05% Difluprednate Ophthalmic Emulsion bottles due to potential contamination from broken protective caps. This may compromise eye drop sterility. Affected products have specific batch numbers and expiration dates.
CiplaJul 14, 2022 - UnratedDrug
CIPLA recalls Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, Goa, India
CIPLA recalls 10mg solifenacin tablets due to manufacturing deviations. Affected lots from June 2021. Consumers should contact for details.
CIPLAJun 10, 2021 - Use cautionDrug
CIPLA recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured
Cipla recalls unit dose packets of Esomeprazole Magnesium 40mg due to cross-contamination with theophylline. Check your lot numbers and expiration date.
CiplaDec 17, 2020 - Lower riskDrug
CIPLA recalls Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Manufactured by Shilpa
Cipla recalls Azacitidine 100 mg vials due to potential sterility issues from improper sealing during manufacturing. Affected vials have specific lot numbers and distribution details. Consumers should contact Cipla for guidance.
CiplaDec 14, 2020
CIPLA recall questions
How many recalls has CIPLA had?
11 recalls from CIPLA are on record with U.S. safety agencies, from 2020–2022.
What is the most recent CIPLA recall?
CIPLA recalls Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile, dated Sep 29, 2022. Every CIPLA recall is listed on this page, newest first.
What should I do if I have a recalled CIPLA product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new CIPLA recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.